Geroprotective and Anticarcinogenic Activity Lifetime Murine Studies Long-term studies in mice demonstrated that DSIP administration over a lifetime decreased total spontaneous tumour incidence 2.6-fold compared to untreated controls, slowed age-related switching-off of oestrous function, decreased the frequency of chromosome aberrations in bone marrow cells by 22.6%, and increased maximum lifespan by 24.1% compared to control groups a multi-parameter geroprotective profile that is among the most striking reported for any short regulatory peptide, and that has generated sustained interest in the DSIP analogue research field
Your provider reviews your health history and confirms the appropriate formulation for your needs
The team takes time to understand each individuals symptoms, lifestyle, and concerns before developing a customized treatment strategy
The measurement of these parameters gave the values that are showed in table III
Most people begin to notice improvements in energy and metabolic efficiency after 6 to 8 weeks of consistent use
Pearsons correlation coefficient was calculated to assess the strength of association between qRT-PCR and RNA-sequencing data